DudeDiligence.

Prothena Corporation plc

PRTANASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$875,975

3 notices · 96,048 sh

Reported ·

$135,927

2 sales · 20 buys · $13.3M bought

All 2 reported sales carry the 10b5-1 box. Together they are 0.03% of the shares on issue.

PLANNED · FORM 144REPORTED · FORM 4D2025J2026FMAMJJASON2026-07-29: ANNE KINGSTON, Form 1442026-07-29: MICHAEL JOHN ISAACS, Form 1442026-06-09: MALECEK MICHAEL J, Form 1442026-05-22: SCULLY WILLIAM P, bought2026-06-02: SCULLY WILLIAM P, bought2026-06-04: SCULLY WILLIAM P, bought2026-06-11: SCULLY WILLIAM P, bought2026-06-16: SCULLY WILLIAM P, bought2026-07-29: Isaacs Michael John, sold2026-07-29: Kingston Anne Evans, sold2026-08-07: SCULLY WILLIAM P, bought2026-08-20: SCULLY WILLIAM P, bought2026-09-02: SCULLY WILLIAM P, bought2026-09-18: SCULLY WILLIAM P, bought2026-09-28: SCULLY WILLIAM P, bought2026-09-29: SCULLY WILLIAM P, bought2026-10-02: SCULLY WILLIAM P, bought2026-10-07: SCULLY WILLIAM P, bought2026-10-13: SCULLY WILLIAM P, bought2026-10-22: SCULLY WILLIAM P, bought2026-11-09: SCULLY WILLIAM P, bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

Jul 29ANNE KINGSTON, Chief Strategy Officer$64,919
7,662 shplan Mar 30144 ↗
Form 4, Jul 30: sold 7,662 at $8.47The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026. Form 4 ↗
Jul 29MICHAEL JOHN ISAACS, General Counsel & Company Sec.$71,055
8,386 shplan Apr 3144 ↗
Form 4, Jul 30: sold 8,386 at $8.47The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 3, 2026. Form 4 ↗
Jun 9MALECEK MICHAEL J, Chief Legal Officer$740,000
80,000 shplan Sep 3, 2025no Form 4 on file144 ↗